You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PERPHENAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Perphenazine, and when can generic versions of Perphenazine launch?

Perphenazine is a drug marketed by Pharm Assoc, Ani Pharms, Appco, Endo Operations, Macleods Pharms Ltd, Mylan, Rising, Sandoz, Watson Labs Inc, Wilshire Pharms Inc, Zydus Pharms, Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Par Pharm, Sun Pharm Industries, and Watson Labs. and is included in forty-nine NDAs.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PERPHENAZINE?
  • What are the global sales for PERPHENAZINE?
  • What is Average Wholesale Price for PERPHENAZINE?
Drug patent expirations by year for PERPHENAZINE
Drug Prices for PERPHENAZINE

See drug prices for PERPHENAZINE

Recent Clinical Trials for PERPHENAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of GuadalajaraPhase 2
Institute of Experimental and Clinical TherapeuticsPhase 2
Hospital Civil de GuadalajaraPhase 2

See all PERPHENAZINE clinical trials

Pharmacology for PERPHENAZINE
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for PERPHENAZINE
Anatomical Therapeutic Chemical (ATC) Classes for PERPHENAZINE

US Patents and Regulatory Information for PERPHENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 070375-001 Aug 25, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms PERPHENAZINE perphenazine TABLET;ORAL 205232-004 Apr 6, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Inc PERPHENAZINE perphenazine TABLET;ORAL 207582-003 Oct 17, 2016 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fosun Pharma PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 071064-001 Nov 27, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 071443-001 Nov 10, 1988 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 073010-001 Oct 17, 1991 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.